Genotype 6 is an uncommon genotype in the United States, but it is highly prevalent in people who have immigrated from parts of Asia. The study will evaluate treatment with Harvoni for 8 weeks compared to a 12-week course of Harvoni. The study will evaluate the safety and effectiveness of the treatment.
Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6
To view the entire clinical trial information, click here